Novus Biologicals™ CD19 Antibody (denintuzumab) - Humanized, Novus Biologicals™

CD19

Flow Cytometry, ELISA, Functional Assay

Unconjugated

Human

Adaptive Immunity, B Cell Development and Differentiation Markers, Cancer Stem Cells, Cytokine Research, Immunology, Innate Immunity, Mesenchymal Stem Cell Markers, Myeloid derived Suppressor Cell, Signal Transduction, Stem Cell Lines, Stem Cell Markers

Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)

B4, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19 antigen, CD19 molecule, CVID3, Differentiation antigen CD19, MGC12802, T-cell surface antigen Leu-12

CD19

Primary

Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.

denintuzumab

Monoclonal

Purified

RUO

Human

P15391

930

IgG1

Protein A purified

Store at -20°C in powder form. Store at -80°C once reconstituted.